JULIANA FERRARO: Open Payments
NPI 1346903960 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 27 payments from 14 companies in 2025. Trend: 2023 $203 · 2024 $150 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $149 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47 |
| ABBVIE INC. | 3 | $44 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| Neos Therapeutics, LP | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Ozempic, ZORYVE, QULIPTA, Wegovy, LEQVIO, The Cologuard Plus Collection Kit, Adzenys XR-ODT, ZEPBOUND.
Industry payments across NJ — which companies pay providers there.
